Digital radiography systems hit marketWidespread availability of digital radiography systems in the U.S. market has finally occurred. In June, Sterling Diagnostic Imaging received Food and Drug Administration 510(k) approval for its DirectRay
Widespread availability of digital radiography systems in the U.S. market has finally occurred. In June, Sterling Diagnostic Imaging received Food and Drug Administration 510(k) approval for its DirectRay operator console (
PNN
7/98), joining Swissray International, Oldelft, and Advanced Instrument Development as companies marketing digital radiography systems.
More recently, Konica won Food and Drug Administration 510(k) clearance for its Regius digital chest system (see story, page 2), while Trex Medical's Continental division announced it will be incorporating AID's digital chest detectors in its x-ray offerings (see story). With end users now having several systems to choose from, the market is truly open for competition.
In other news, PACS & Networking News has launched its Web site, called PNN Online. On the site (www.pacsnews.com), subscribers will be able to view stories online from PNN issues up until April 1998. Please see the enclosed insert for the correct user name and password to access the articles.
Other PNN Online features include subscription services, in which readers can submit address changes, as well as new and renewal subscriptions. We'll also soon be adding useful PACS site links.
But PNN Online is not the only World Wide Web site PACS enthusiasts can visit for useful information on digital image management. Our sister publication Diagnostic Imaging (www.dimag.com) is hosting a Virtual Symposium called Peers on PACS, which will run until August 2. Archives of the online event will be available for viewing after the symposium.
-Erik L. Ridley, Editor
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.